Ignite Creation Date:
2024-05-06 @ 7:51 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06158854
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2023-11-28
Brief Title:
A Study to Assess Change in Disease Activity and Adverse Events AEs in Adult Participants With Immunoglobulin Light Chain AL Amyloidosis Receiving ABBV-383 as an Intravenous IV Infusion
Sponsor:
AbbVie
Organization:
AbbVie
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-02-23
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-28
First Submit QC Date:
November 28 2023
Study First Post Date:
2023-12-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-30
Last Update Post Date:
2024-07-11
Last Update Post Date Type:
ACTUAL